未登录

Q

Quansheng Zhou

soochow university - china

H指数:41

被引数:4,629

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diphthamide deficiency promotes association of eEF2 with p53 to induce p21 expression and neural crest defects

NATURE COMMUNICATIONS

IF15.7

2024-04-261

OAAI

Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways

CELLULAR ONCOLOGY

IF4.8

2023-11-041

OAAI

Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-11-014

PRE

The long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers

CELL DEATH & DISEASE

IF9.6

2023-04-2510

OAAI

The negative c-Myc target onzin affects proliferation and apoptosis via its obligate interaction with phospholipid scramblase I

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2753

OAAI

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-2711

OAAI

Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins

BREAST CANCER RESEARCH

IF5.6

2021-12-1820

OAAI

Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy

致癌癌症/睾丸抗原是癌症的标志，也是癌症免疫治疗的明智目标

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2021-08-0128

PREAI

Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis

BIOCHEMICAL PHARMACOLOGY

IF5.6

2021-03-019

PREAI

The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer

CURRENT MEDICINAL CHEMISTRY

IF3.5

2020-10-0825

PRE

Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy

CELL DEATH & DISEASE

IF9.6

2020-05-2119

OAAI

The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy (vol 73, pg 451, 2020)

CELL DEATH AND DIFFERENTIATION

IF15.4

2020-04-061

OAAI

The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy

CELL DEATH AND DIFFERENTIATION

IF15.4

2020-03-0628

OA

Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notchl and NF-κB signaling pathways

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2020-02-0129

PREAI

Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth

BIOCHEMICAL PHARMACOLOGY

IF5.6

2019-08-0123

PREAI

Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation

VASCULAR PHARMACOLOGY

IF3.5

2019-06-016

PREAI

Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2019-02-0134

PREAI

Proteomic profiling of zinc-induced skin cell proliferation: Activation of β-catenin pathway

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-05-010

OAAI

Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes

Triptonide通过抑制ve-cadherin和趋化因子配体2基因的表达有效抑制胰腺癌细胞介导的血管生成拟态

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2018-01-0154

PREAI

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

IF3.4

2017-11-0315

OAAI